A review of economic evaluation in osteoporosis

Arthritis Care and Research

Volumn 12, Issue 6, 1999, Pages 425-434

  Cranney, A ^a   Coyle, D ^a   Welch, V ^a   Lee, K M ^a   Tugwell, P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; HORMONE SUBSTITUTION; MONITORING; OSTEOPOROSIS; QUALITY OF LIFE; REVIEW; SCREENING; SOCIOECONOMICS;

EID: 0033303339     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199912)12:6<425::aid-art11>3.0.co;2-a     Document Type: Review

References (45)

1. A Summary of economic evaluations published in the field of rheumatology and related disciplines
2. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis, status report
3. Current and projected rates of hip fractures in Canada
4. Economic evaluation of interventions in endocrinology
5. Hormone replacement therapy. I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency
6. Application of cost-effectiveness analysis to post-menopausal estrogen therapy
7. Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy
8. Prevention of osteoporosis - A cost-effectiveness analysis regarding fractures
9. Cost-effectiveness of fracture prevention in established osteoporosis
10. Fracture prediction models for osteoporosis prevention
11. Perimenopausal bone density screening - Will it help prevent osteoporosis?
12. Maximising the cost effectiveness of BMD referral for DXA using ultrasound as a selective population pre-screen
13. Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture
14. Using economics to prioritize research: A case study of randomized trials for the prevention of hip fractures due to osteoporosis
15. Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium
16. Osteoporosis clinical trials endpoints: Candidate variables and clinimetric properties
17. Grades of recommendation for antithrombotic agents
18. Screening and treatment in the elderly to reduce osteoporotic fracture risk
19. Hormone therapy to prevent disease and prolong life in postmenopausal women
20. Prevention of osteoporosis: Cost-effectiveness of different pharmaceutical treatments
21. Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis
22. Economic analysis of health care technology: A report on principles
23. The Osteoporosis Assessment Questionnaire (OPAQ): A reliable and valid self-assessment measure of quality of life in osteoporosis
24. Impact of hormone replacement therapy (HRT) on quality of life
25. Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO)
26. Quality of life issues in women with vertebral fractures due to osteoporosis
27. Use of alendronate in osteoporosis - Is it cost-effective?
28. Postmenopausal estrogens in prevention of osteoporosis
29. HRT: An analysis of benefits, risks and costs
30. Cost-effectiveness of hormone replacement therapy in the menopause
31. Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use?
32. Impact of hormonal prevention on fractures of the proximal femur in postmenopausal women: A simulation study
33. Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy
34. A comparison of the effectiveness and cost of treatment for vertebral fractures in women
35. Hormone replacement therapy in a risk-benefit perspective
36. A cost-effectiveness analysis of hormone replacement therapy in the menopause
37. Estrogen use in postmenopausal women - Costs, risks, and benefits
38. Use of cyclical etidronate and prevention of non-vertebral fractures
39. Targeted estrogen/progesterone replacement therapy for osteoporosis: Calculation of health care cost savings
40. Cost-effectiveness of hormone replacement therapy after the menopause
41. Cost-effectiveness of hormone replacement